Extrahepatic Applications of Yttrium-90 Radioembolization. [PDF]
Semin Intervent Radiol, 2021 AbstractWhile initially described and now accepted as treatment for primary and secondary malignancies in the liver, radioembolization therapy has expanded to include treatment for other disease pathologies and other organ systems. Advantages and limitations for these treatments exist and must be compared against more traditional treatments for these ...
Murali N +4 more
europepmc +3 more sources
Lung Shunt Reduction for Yttrium-90 Radioembolization: Chemoembolization Versus Radioembolization. [PDF]
In Vivo, 2021 To evaluate the efficacy of chemoembolization versus radioembolization in reducing lung shunt fraction (LSF) in patients with hepatocellular carcinoma (HCC).In this retrospective study, from March 2012 to January 2021, 457 patients with HCC underwent planning angiography and 99mTc-macroaggregated albumin imaging for possible yttrium-90 ...
Kim HC +5 more
europepmc +4 more sources
Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma [PDF]
OncoTargets and Therapy, 2015 published_or_final_versio
Kwong, DLW +9 more
core +7 more sources
Yttrium-90 Radioembolization Therapy for Combined Hepatocellular and Cholangiocarcinoma. [PDF]
Gastrointest Tumors, 2020 <b><i>Purpose:</i></b> To report outcomes of transarterial radioembolization (TARE) using glass microspheres for the treatment of mixed hepatocellular-cholangiocarcinoma (HCC-CC) in a propensity-matched study. <b><i>Material and Methods:</i></b> Between 2013 and 2019, 10 consecutive patients with ...
Badar W +6 more
europepmc +4 more sources
Role of Yttrium-90 Radioembolization for Colorectal Hepatic Metastasis. [PDF]
Korean J Radiol, 2022 Kim HC.
europepmc +4 more sources
Side Effects of Yttrium-90 Radioembolization [PDF]
Frontiers in Oncology, 2014 Limited therapeutic options are available for hepatic malignancies. Image guided targeted therapies have established their role in management of primary and secondary hepatic malignancies. Radioembolization with yttrium-90 ((90)Y) microspheres is safe and efficacious for treatment of hepatic malignancies.
Riaz, Ahsun, Awais, Rafia, Salem, Riad
openaire +3 more sources
Yttrium-90 Radioembolization Dosimetry: What Trainees Need to Know. [PDF]
Semin Intervent Radiol, 2020 Villalobos A +6 more
europepmc +4 more sources
Yttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature Review. [PDF]
, 2016 Hepatocellular carcinoma is the most common primary liver cancer and it represents the majority of cancer-related deaths in the world. More than 70% of patients present at an advanced stage, beyond potentially curative options.
Alanis, Lourdes +3 more
core +1 more source
Transarterial RAdioembolization versus ChemoEmbolization for the treatment of hepatocellular carcinoma (TRACE) : study protocol for a randomized controlled trial [PDF]
, 2012 Background: Hepatocellular carcinoma is a primary malignant tumor of the liver that accounts for an important health problem worldwide. Only 10 to 15% of hepatocellular carcinoma patients are suitable candidates for treatment with curative intent, such ...
Al Younis, Imad +11 more
core +1 more source
PET/MRI of Hepatic 90Y Microsphere Deposition Determines Individual Tumor Response. [PDF]
, 2016 PurposeThe purpose of our study is to determine if there is a relationship between dose deposition measured by PET/MRI and individual lesion response to yttrium-90 ((90)Y) microsphere radioembolization.Materials and methods26 patients undergoing lobar ...
Fowler, Kathryn J +7 more
core +2 more sources